FLG and Alzheimer disease: Therefore, we conclude that n-hexadecanoic acid, oleic acid, and octadecanoic acid have the best potential to be used as drug candidates for the treatment of AD, and filaggrin may be the drug target of the anti-AD effect (Earlia et al., 2019).